跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
REFRAT CAPSULES 250MG
Approved
THERAPEUTIC
REFRAT CAPSULES 250MG
STRIDES PHARMA SCIENCE LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 20, 2014
Approval ID
951af1a89bc3809c
Company
STRIDES PHARMA SCIENCE LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
951af1a89bc3809c
Drug Name
REFRAT CAPSULES 250MG
Product Name
REFRAT CAPSULES 250MG
Approval Number
SIN14674P
Approval Date
2014-11-20
Registrant
STRIDES PHARMA GLOBAL PTE. LIMITED
Licence Holder
STRIDES PHARMA GLOBAL PTE. LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L04AA06
Atc Item Name
mycophenolic acid
Pharma Manufacturer Name
STRIDES PHARMA GLOBAL PTE. LIMITED
Company Detail Path
/organization/strides-pharma-global-pte-limited
Active Ingredients
Mycophenolate mofetil
250mg
MYCOPHENOLATE MOFETIL
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 20, 2014
Approval ID
951af1a89bc3809c
Type
Therapeutic
Back to HSA Approvals
REFRAT CAPSULES 250MG - HSA Drug Approval Details